Growing cardiovascular disease, public-access AED programs, and rising demand in hospitals & pre-hospital settings drive the EMEA cardiac arrest treatment market from US$1.26 B (2024) to US$2.33 B by 2033 at ~7.3% CAGR. Aging demographics and government legislation for defibrillator coverage are key growth levers across Europe, the Middle East, and Africa. https://www.datamintelligence.com/research-report/emea-cardiac-arrest-treatment-market